Ticker

No recent analyst price targets found for DOSEF.

Latest News for DOSEF

Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform

KELOWNA, BC, March 30, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD |OTCQB: DOSEF | FSE: VU70 ) ("Doseology" or the "Company") a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it has arranged a non-brokered private placement of up to 3,225,806 units (each, a "Unit") at a price of $0.62 per Unit to raise aggregate gross proceeds of up…

PRNewsWire • Mar 30, 2026
Doseology Uplists to OTCQB as DOSEF, Expanding U.S. Investor Access to the Emerging Oral Stimulant Pouch Category

KELOWNA, BC, March 11, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a consumer product innovation company focused on oral stimulant pouch technologies, is pleased to announce that its common shares have commenced trading on the OTCQB® Venture Market in the United States under the symbol DOSEF. "We are pleased to expand trading access for U.S.…

PRNewsWire • Mar 11, 2026
Doseology Launches Feed That Brain® Oral Stimulant Pouches in the U.S. Through Direct-to-Consumer Pilot

KELOWNA, BC, March 4, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) ("Doseology" or the "Company") today announced the launch of the Feed That Brain® Energy Pouches, marking the Company's first direct-to-consumer pilot program in the United States. Feed That Brain Energy Pouches deliver clean, controlled energy in a discreet oral pouch format, powered by Doseology®.

PRNewsWire • Mar 4, 2026
Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors

VANCOUVER, BC, Feb. 20, 2026 /PRNewswire/ -- Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") is pleased to announce the appointment of Larry Latowsky as a director and the Executive Chairman of its Board of Directors, effective February 18, 2026. Doseology is focused on developing precision-controlled oral delivery systems within the emerging oral stimulant category.

PRNewsWire • Feb 20, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for DOSEF.

No Senate trades found for DOSEF.

No House trades found for DOSEF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top